You're reading the free version. Trader adds the live tape and alerts.
Start tracking
DNLI Award Disclosure
Baker Bros. Advisors Lp · SEC Form 4 · Filed Jun 5, 2026
Award
Calculated transaction value
$0
Baker Bros. Advisors Lp Director
DNLI
Transaction date
Jun 3, 2026
Public filing date
Jun 5, 2026
Filing lag
Filed 2 days later
DNLI daily price context
Close on/before transaction
$19.66
Jun 3, 2026
First close after public filing
$19.54
Jun 8, 2026
30-day return after filing
+31.73%
Through Jul 6, 2026
Source details
- Reported owner
- Not disclosed
- Source asset code
- Security
- Security
- Common Stock
- Quantity / price
- 6,408 shares @ $0
- SEC ownership
- Indirect
- Transaction code
- A
- Form
- 4
- Filing identifier
- 0001193125-26-259680
Filing cohort
Transactions in this filing
Showing 4 of 4
Trades
4
Issuers
1
Estimated value
$0
Buys / sales
0 / 0
| Issuer | Transaction | Traded | Value |
|---|---|---|---|
| Denali Therapeutics Inc. DNLI Current | Award | Jun 3, 2026 | $0 |
| Denali Therapeutics Inc. DNLI | Award | Jun 3, 2026 | $0 |
| Denali Therapeutics Inc. DNLI | Award | Jun 3, 2026 | $0 |
| Denali Therapeutics Inc. DNLI | Award | Jun 3, 2026 | $0 |